NG
Nirmal Gangwani
About Nirmal Gangwani
Data last updated:
Nirmal Gangwani is an Additional Director at Razenta Pharmaceuticals Private Limited (since 2022), Director at Sage Wellness Private Limited (since 2022) and Director at Rpm Pharma Solutions Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Chemicals and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹3.52 Cr; the largest is Razenta Pharmaceuticals Private Limited at ₹3.34 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Razenta Pharmaceuticals Private Limited U24299MP2021PTC057399 | Additional Director | 01 Mar 2022 | 2021 | ₹3.34 Cr (FY 2025) | Active |
| Sage Wellness Private Limited U85110MP2022PTC070605 | Director | 18 Apr 2022 | 2022 | ₹18.8 Lakh (FY 2025) | Active |
| Rpm Pharma Solutions Private Limited U46497MP2025PTC079266 | Director | 23 Sep 2025 | 2025 | Active | |
| Designated Partner | 21 Feb 2017 | 2017 | Active |
Board colleagues of Nirmal Gangwani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pushpendra Kumar Tiwari | 09311930 | Razenta Pharmaceuticals Private Limited | Director |
| Rajesh Kumar Tiwari | 09311931 | Razenta Pharmaceuticals Private Limited | Director |
| Yunus Ahamad | 09383899 | Razenta Pharmaceuticals Private Limited | Additional Director |
| Harish Gangwani | 07732821 | Sage Wellness Private Limited , Rpm Pharma Solutions Private Limited and 1 more | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nirmal Gangwani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirmal Gangwani
Nirmal Gangwani currently holds 4 directorships: Razenta Pharmaceuticals Private Limited (Additional Director, since 01 Mar 2022, revenue ₹3.34 Cr (FY 2025)); Sage Wellness Private Limited (Director, since 18 Apr 2022, revenue ₹18.8 Lakh (FY 2025)); Rpm Pharma Solutions Private Limited (Director, since 23 Sep 2025); Shreesiddhivinayak Multispeciality Hospitals India Llp (Designated Partner, since 21 Feb 2017).
Nirmal Gangwani was first appointed on 21 Feb 2017 as Designated Partner at Shreesiddhivinayak Multispeciality Hospitals India Llp. The most recent appointment on record is 23 Sep 2025 at Rpm Pharma Solutions Private Limited.
The 2 current companies of Nirmal Gangwani that report revenue have a combined latest revenue of ₹3.52 Cr: Razenta Pharmaceuticals Private Limited ₹3.34 Cr (FY 2025); Sage Wellness Private Limited ₹18.8 Lakh (FY 2025).
The current boards of Nirmal Gangwani's companies include Pushpendra Kumar Tiwari (Razenta Pharmaceuticals Private Limited), Rajesh Kumar Tiwari (Razenta Pharmaceuticals Private Limited), Yunus Ahamad (Razenta Pharmaceuticals Private Limited), Harish Gangwani (Sage Wellness Private Limited).